Summary Two human cell lines (UACC-812 and 893), both containing significant amplification of the HER-2/neu gene, were established from biopsy specimens of breast carcinomas. One patient had Stage II breast carcinoma; the other had metastatic disease. Characterisation of these lines has revealed that both are highly aneuploid containing multiple clonal chromosome alterations, have doubling times near 100 h, and are oestrogen and progesterone receptor negative. Electron microscopy demonstrates that both lines contain numerous microvilli, cytoplasmic filaments, multivesicular bodies, and desmosomes. Immunoblot analysis for P-glycoprotein using the monoclonal antibody C219 was negative for both patient cell lines. These relatively rare cell lines may represent a useful model to investigate human breast carcinomas.
Despite intensive efforts over the past 50 years, establishment of human breast cancer cell lines from breast tumour tissue has been largely unsuccessful (Smith et al., 1984) . Only 12 bona fide characterised cell lines have been reported in the literature (Table I ). The establishment and some characterisation of the two new breast tumour cell lines -UACC-812 and UACC-893 -has been previously reported (Leibovitz et al., 1988) . The biologic characteristics of these two lines havebeen further analysed with respect to their in vitro growth properties, cellular ultrastructure, hormone receptor status, drug sensitivity and cytogenetic profile. Of primary interest, both cell lines exhibit amplification of the HER-2/neu oncogene.
Materials and methods

Patient information
The UACC-812 cell line was derived from a biopsy of the left breast of a 42-year old women with infiltrating ductal carcinoma, grade 2, Stage IV (Figure la). Three years prior to this biopsy, she was diagnosed as having mammary cancer of the right breast, refused surgical intervention, and was treated solely with chemotherapeutic agents (doxorubicin and cyclophosphamide). Metastases to the right neck occurred 2 years later and the patient was retreated with combination chemotherapy (5-fluorouracil, doxorubicin and cyclophosphamide). A clinical complete response was obtained after six courses of therapy; however, 8 months after the completion of therapy, she developed liver metastases and a large mass in the left breast. The breast tumour was oestrogen receptor and progesterone receptor negative. Mastectomy was performed and a large tumour mass (6.0 x 6.0 x 8.0 cm) was removed and an aliquot submitted for tissue culture. DNA flow cytometry showed aneuploidy with a DNA index of 1.59.
The UACC-893 cell line was derived from an infiltrating ductal carcinoma of the right breast of a 57-year old women who had a negative mammogram 11 months prior to diagnosis. The tumour, dissected from a lumpectomy, measured 1.8 x 1.0 x 0.8 cm, grade 2 ( Figure lb) . Four of seven axillary lymph nodes were positive for metastatic disease. This patient developed metastatic disease and died of disease within 3 years of diagnosis despite receiving adjuvant chemotherapy with doxorubicin, cyclophosphamide and 5-fluorouracil. Oestrogen and progesterone receptors were negative and DNA flow cytometry showed aneuploidy with a DNA index of 1.72. An aliquot of the primary tumour tissue was submitted for this culture.
Transport medium Tissue specimens derived from presumed breast carcinomas were transported to the tissue culture laboratory in medium L15MI5 (Table II) . This detoxification-growth medium preserves tissue viability for at least 4 days (Kischer et al., 1989) .
Tissue processing
The tissues were debrided of normal tissue, necrotic areas and blood clots and placed in a sterile Petri dish containing about 15 ml of medium Mi5, and processed after the method of Leibovitz et al. (1976) . Specifically, the tissue was sliced with crossed surgical blades into 1 mm cubes. The medium surrounding the cubes was harvested for the spillout and fine-mince cultures (Leibovitz et al., 1976 least 5 x 105 per flask, were obtained, all media were compared for both short-term and long-term growth. When longterm growth was obtained, medium M13 with 2-5% foetal bovine serum (FBS) usually sufficed. Medium L15 with 5-10% FBS (readily available from commercial sources) yields excellent growth for the established cell lines.
Tissue cell culturing As the media are bicarbonate and glucose free, all culturing could be done in closed systems (screw capped flasks; Falcon) in a regulator incubator at 36-37C with minimal fluctuations in pH. Initial explants were made on collagen coated flasks [after the method of Macklis et al. (1985) ]. Flasks were examined daily for the first week. Those containing tumour cells in suspension were harvested by centrifugation and re-seeded in a fresh collagen-coated screw capped flask. One or more of the flasks containing tumourlike cells were sacrificed within 7 days for cytogenetic studies; the rest were retained for long-term growth studies. Flasks containing moderate to large numbers of tumour-like cells were fed once per week. Those containing small numbers of tumour-like cells were not refed, but had 1 ml of fresh media added per week until growth started.
Geneticin eradication offibroblasts Flasks containing tumour-like cell colonies firmly attached to the plastic and contaminated by fibroblast outgrowth were refed with M15 containing 100 tg ml1' Geneticin Hayflick (1973) , as modified by Leibovitz et al. (1976) , was used to obtain the generation time of each cell line. All subcultures were 1:2 splits using 0.25% trypsin -0.1% EDTA in Dulbecco's basic salt solution without calcium or magnesium (Irvine Scientific).
Electron microscopy In preparation for transmission electron microscopy (TEM), cells were rinsed in 0.2 M phosphate buffer, immersed in modified Karnovsky's fixative for 1 h, rinsed again in phosphate buffer, and post-fixed in 2% osmium tetroxide for 45 min in the dark. Subsequently, cells were rinsed in phosphate buffer, dehydrated in increasing concentrations of ethanol, and embedded in Spurr resin. Ultrathin sections were cut on a Porter-Blum MT-2B ultramicrotome, stained with uranyl acetate and Reynold's lead solution, and examined using a Philips 300 transmission electron microscope (operating at 60 KV accelerating voltage).
Oestrogen and progesterone receptors Cell pellets were prepared and stored in -80°C. A cytostolic extact was obtained from passage 5 on UACC-812 and passage 9 on UACC-893 and analysed as previously described (Kute et al., 1980) . Results are reported in femtomoles per mg of protein and results were defined as positive if there was > 10 femtomole mg-I of protein and the affinity constant was >5 x 108 M-1. Positive and negative cytosolic material was analysed at the same time for quality control.
Histochemistry
Tissue cells were grown on coverslips, washing in PBS for 5 min, fixed in cold methanol for 5 min, and then in acetone for 5 s to assure permeabilisation. After 5 additional min in PBS, the cells were incubated with the desired antibody for 30 min, washed in PBS for 5 min and then incubated with fluorescinated goat anti mouse IgG (Cappel, Durham NC) for 30 min. Coverslips were then washed with PBS, mounted and observed with a Zeiss epifluorescent microscope. Antibodies were anticytokeratins KAI and KA4 (Nagle et al., 1986) , anticytokeratin 10.1 1 (Chan et al., 1986) , anti-vimentin (Dako) and anti-HER-2 (Triton Biosciences). UACC was studied at passage 36 and UACC 893 was studied at passage 9.
Cytogenetics
Exponentially growing cultures were harvested for karyotypic analysis, slides prepared, and Q-or G-banding performed as previously described (Trent & Thompson, 1987) . >50 cells per cell line were analysed, with results expressed according to ISCN recommendations (1985) .
Immunoblot analysis Plasma membrane preparations from UACC 812 and UACC 893 were prepared according to the method of Riordan and Ling (1979) . Cell lines known to be negative (8226/S) and positive (8226/Dox4O) for over expression of P-glycoprotein wre used as controls (Dalton et al., 1986) . Polyacrylamide gel electrophoresis was performed according to the method of Fairbanks et al. (1971) with slight modification (Delenham et al., 1982) . The procedure of Towbin et al. (1979) was used to transfer proteins from the gel to nitrocellulose paper which was then probed with the monoclonal antibody C-219 (Centocor). '251-rabbit anti-mouse IgG (New England Nuclear Corp.) was used as a second antibody for detection by autoradiography.
In vitro drug sensitivity testing A modified protein detection system was used to calculate cell survival following exposure to chemotherapeutic drugs (Bradford et al., 1976) . Single cell suspensions of the cell lines obtained in the exponential phase of cell growth were placed in the M-3 growth medium (Leibovitz, 1985) and plated at 30,000 cells/well in 96-well plates. Following a 5 day incubation with varying doses of drug, the media plus drug was aspirated from individual wells. Fifty itl of H20 was then added to each well, and after three freeze thaw cycles, 200 gl of Bio-Rad Protein Assay Reagent (Bio-Rad Laboratories) diluted 1:5 was added to each well. The absorbance of each well was read at 595 nm using a Dynatech MR600 microplate reader (Dynatech Laboratories). Controls included medium plus the highest drug concentration and cells with medium only. The percentage of survival was calculated by dividing the absorbance of drug treated cells by the absorbance of control cells.
Isolation of DNA and Southern blotting High molecular weight genomic DNA was isolated by SDSproteinase K lysis, organic extraction, and NaCI-ethanol precipitation (Maniatis et al., 1982) . The DNA was quantitated by the 4, 6-diamine 2-phenylindole dihydrochloride method (Kapuscinski & Skoczylas, 1977) . Ten ig of DNA was digested with HindIII, electrophoreses in 0.8% agarose, and transferred to a Gene Screen membrane (Southern, 1975) . Membranes were hybridised with the 440bp KpnlXbal fragment of HER-2, pKX044 (kindly provided by T. Yamamoto, University of Tokyo) labelled by the method of Feinberg and Vogelstein (1984) .
Results
DNA flow cytometry Both neoplasms were aneuploid; the original breast tumour tissue and cell lines were in agreement; UACC-812 had a DNA index of 1.59, UACC-893 DNA index was 1.72.
Establishment of cell lines
The UACC-812 biopsy specimen yielded 1.8 x I07 viable cells and growth was obtained on all media (MI9, 33 and 41) tested; the best growth was on medium 41 which was used to establish the cell line. However, by the 6th passage, the cells could be maintained on M13, 5% FBS or L15, 5% FBS. Aliquots were frozen down under liquid nitrogen in 2nd, 5th, 10th, 15th and 20th passages. There was minimal stromal contamination, and cells were first subcultured in 3 weeks.
The UACC-893 biopsy specimen yielded 2.1 x 106 viable cells. Initial tumour-like epithelial cells were evident in the initial outgrowth of all media tested (M15, 19, 41, 49, 50, 51, 52) but degenerated in all flasks except in one (M41) where a few colonies persisted and started to proliferate. Fibroblastlike cells started to overgrow the tumour colonies, but were eradicated by geneticin treatment. It required 4 months before these cells could be successfully subcultured. Cells were frozen down in the 3rd, 6th, 7th, 10th, 15th and 20th passages. By the 9th passage, the less complex medium M19 could readily be used for maintenance, but the cells still required pituitary extract for optimal growth. By the 13th subculture, M13 or L15, with 10% foetal bovine serum sufficed.
By light microscopy, both cell lines demonstrate an epithelioid morphology in vitro (including distinct nuclei and nucleoli and a cobblestone 3-dimensional growth) that is retained throughout numerous subcultures (Figure 2 ). Both UACC-812 and UACC-893 grow as slowly expanding colonies with defined boundaries. Cells at confluence grow predominantly 3-dimensionally as monolayers with multilayering. Occasionally, there was doming of cells. The cell doubling time for UACC-812 is 100 h, while the UACC-893 P-glycoprotein at a detectable level using this assay (data not cell line displays a doubling time of 120 h. Both cell lines shown). have now been subcultured >50 times.
Electron microscopy
Ultrastructural analysis of both cell lines further documents the epithelioid nature of both cell lines (Figure 3) . Electron a .6; ,l ,i;} microscopy performed at passage 6 for UACC-812 and passage 13 for UACC-893 demonstrated specialised junctions, including desmosomes as well as cytoplasmic filaments, multivesicular bodies, and prominent surface microvilli. Histochemistry UACC-812 (passage 36) and UACC-893 (passage 9) had identical reactivity on immunohistochemical analysis (Table  III) (Figure 4 ) was characterised by numeric alterations (most notably chromosome loss) and the presence of seven unidentifiable marker chromosomes. Clonal structural alterations included: t(l;3)(pl l;pl 1); t(l;7)(pl3;ql 1); iso(6p); del(6)(q23); iso(7q);del(1l)(pl3); and t(l l;'?)(pl4;?).
The karyotype of UACC-812 demonstrated a modal range of 58-64 and displayed numerous numeric and structural changes. As illustrated in Figure 5 , the presence of multiple unidentifiable marker chromosomes, rings, and an abnormal chromosome 3 (-2.2 x the side of a normal 3) were observed. This latter chromosome was formed from the tgeneration of an abnormally banding region on chromosome d 3p. Clonal structural changes for UACC-812 included: del (2) ....¢IO, (q24); t(2;?)(q37;?); HSR(3)(p21); del(7)(q22);t(7;?)(q36;?); iso(8q); del(9)(pl 3); del(l l)(p13); t(21;?)(q22;?).
HER-2/neu amplification Figure 6 shows a Southern blot of HindIII digested DNA from normal placenta and the UACC-812 and UACC-893 cell lines, and evidence for HER-2/neu amplification can be Figure 7 shows the cell survival curves for the two patient cell lines, compared to the well-known breast cancer cell line, when (Salmon et al., 1989) , the two lines we have established failed to significantly express this protein. Cell line UACC-893 was derived from a patient with primary Stage II breast cancer, whereas UACC-812 was obtained from a patient with recurrent metastatic disease, Stage II, grade IV, who had received extensive prior cytotoxic chemotherapy. It is possible that alternate mechanisms of multidrug resistance (Slovak et al., 1988; Mirski et al., 1987; Batist et al., 1986 ) may be responsible for the relative drug resistance observed in vitro and the clinical drug resistance observed for the patient with Stage IV disease (UACC-812). Alternatively, it is equally possible that the long duration of cell culture required prior to cell passage and analysis for both lines eliminated cells differentially expressing P-glycoprotein.
The success rate of establishing cell lines from tumours in breast tissue has not progressed significantly since Lasfargues and Ozello established the first one over 30 years ago (1958) . Only 13 additional cell lines have been added in spite of intensive effort by many investigators (Table I ). The common features of all established cell lines including ours are: all are hyperdiploid; when determined by the authors, all had metas- In our laboratory, only these two out of about 100 primary breast specimens have resulted in established cell lines. However, more than 80% of the specimens yielded <1 x 106 total viable cells (stromal and tumour cells). Most of these were in a milieu of dead and dying cells; the average viability of cell yields was about 20% with a range of < 1% to 50%. Short-term cultures were obtained in approximately 80% of specimens. Typical adenocarcinoma-type islands of epitheliallike cells which were present in most instances, were useful for obtaining cytogenetic studies shortly after explantation, but invariably these died out within a few weeks. The specimens yielding cell lines were from fairly large tumours (UACC-812 had over 107 viable tumour cells and UACC-893 had over 106 viable tumour cells).
Three other cell lines (Table I) -VHB-1 (Vandewalle et al., 1987) , CAL 18A and CAL 18B (Gioanni et al., 1985) -were derived from patients with a similar clinical history as our UACC-8 12. The patients refused surgical intervention for their original tumour and were treated by radiation and/or chemotherapy with clinical remission. However, after about 2 years, relapses occurred with carcinomas developing in the same breast or the other breast as well as metastasis to other sites. These tumour cells adapted readily to in vitro growth and cell lines were established with little difficulty.
Our experience in establishing the UACC-893 cell line duplicates the findings of Lasfargues et al. (1978) for and Yamane et al. (1984) for YMB-1. Although tumour-like cells were evident on original explants, most of them died out and the cell lines were established from small clusters of tumour cells that persisted and finally started to proliferate. Four to 5 months elapsed before a successful subculture could be made. Kraus et al. (1987) found four of 11 established breast cell lines to have HER-2/neu amplification. These included one of three cell lines derived from breast tissue (BT474) and three of eight from pleural fluid (SK-BR-3, MDA-MB-361 and MDA-MB-453). This -33% rate correlates reasonably well with studies done in primary tissue (Slamon et al., 1987; Berger et al., 1988) .
In conclusion, our experience describes the successful establishment of two breast carcinoma cell lines. Because of the potential importance of the HER-2/neu gene to the biology (and clinical course) of breast cancer, these lines may represent a useful model to investigate the pathogenesis of this disease. These cultures will be transmitted to the American Type Culture Collection for distribution to interested investigators.
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